ID
38164
Description
Study ID: 105-123 Clinical Study ID: 105-123 Study Title: Lamotrigine as add-on therapy in patients with clinical diagnosis of a Lennox-Gastaut syndrome (severe generalised epilepsy of childhood onset.) A multicentre, double-blind, placebo controlled parallel group study Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Lamotrigine Study Indication: Seizures
Mots-clés
Versions (1)
- 23/09/2019 23/09/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
23 septembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Lamotrigine as add-on therapy in patients with a clinical diagnosis of a Lennox-Gastaut syndrome (105-123)
Study Termination Record
- StudyEvent: ODM
Description
Study Termination
Alias
- UMLS CUI-1
- C0008972
- UMLS CUI-2
- C0013135
Description
Did the patient complete 16 weeks of the study?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348577
Description
Did the patient discontinued prematurely?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2718058
Description
If the patient completed 16 weeks did he/she continue/ start lamotrigine treatment?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348577
- UMLS CUI [2,1]
- C0064636
- UMLS CUI [2,2]
- C0549178
- UMLS CUI [3,1]
- C0064636
- UMLS CUI [3,2]
- C0439659
Description
If the patient completed 16 weeks did he/ she taper off study medication from week 16?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348577
- UMLS CUI [2,1]
- C0441640
- UMLS CUI [2,2]
- C0304229
Description
If the patient discontinued prematurely, was the discontinuation due to an adverse experience regardless of association with the test agent?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2718058
- UMLS CUI [2]
- C0877248
- UMLS CUI [3,1]
- C0013230
- UMLS CUI [3,2]
- C0439849
Description
Did the patient die during the study?
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C0008976
Description
If patient died, enter date of Death
Type de données
date
Alias
- UMLS CUI [1]
- C1148348
Description
Cause of Death
Type de données
text
Alias
- UMLS CUI [1]
- C0007465
Description
Please chek on only.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2718058
- UMLS CUI [1,2]
- C3840932
Description
Investigator's Statement
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C1710187
Description
I confirm that I have carefully examined all entries on the Case Report Forms for this patient. All Information entered by myself or my colleagues is, to the best of my knowledge, correct as of the date below.
Type de données
text
Alias
- UMLS CUI [1,1]
- C1519316
- UMLS CUI [1,2]
- C1521895
Description
Prinicpal Investigator's Name
Type de données
text
Alias
- UMLS CUI [1]
- C2826892
Description
Date of Signature
Type de données
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Study Termination Record
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0064636 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
C0064636 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
C0441640 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0877248 (UMLS CUI [2])
C0013230 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C3840932 (UMLS CUI [1,2])
C1710187 (UMLS CUI-2)
C1521895 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Aucun commentaire